Literature DB >> 19619123

Tryptophan fluorescence quenching by enzyme inhibitors as a tool for enzyme active site structure investigation: epoxide hydrolase.

Evgenia G Matveeva1, Christophe Morisseau, Marvin H Goodrow, Chris Mullin, Bruce D Hammock.   

Abstract

We present the strong fluorescence effect, a new 392 nm emission peak appearing after binding of a naphtol-urea inhibitor XIIa to the enzyme epoxide hydrolase (EH), along with the quenching of the EH tryptophan fluorescence. We have studied the quenching of the 392-nm peak (attributed to XIIa bound inside the active center of the enzyme) of the mixture EH +XIIa by various strong transparent inhibitors (competing with XIIa for binding to EH), and measured the corresponding values of the Stern-Volmer constants, K(mix)(SV). Strong EH inhibitors demonstrate different replacement behavior which can be used to distinguish them. We further demonstrate a novel fluorescent assay which allows to distinguish highly potent inhibitors and to visualize the strongest among them. We generated our assay calibration curve based on the quenching data, by plotting quenching strength K(mix)(SV) versus inhibiting strength, IC(50) values. We used moderate inhibitors for the assay plot generation. We then applied this curve to determine IC(50) values for several highly potent inhibitors, with IC(50) values at the limit of the IC(50) detection sensitivity by colorimetric enzyme assay. IC(50) values determined from our quenching assay show correlation with IC(50) values determined in the literature by more sensitive radioactive-based assay and allow differentiating the inhibitors potency in this group. To our knowledge, this is the first inhibitor assay of such kind. Chemical inhibition of EH is an important technology in the treatment of various cardiovascular diseases, therefore, this tool may play a crucial role in discovering new inhibitor structures for therapeutic EH inhibition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19619123      PMCID: PMC2861369          DOI: 10.2174/138920109789069260

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  32 in total

1.  Affinity purification of cytosolic epoxide hydrolase using derivatized epoxy-activated Sepharose gels.

Authors:  R N Wixtrom; M H Silva; B D Hammock
Journal:  Anal Biochem       Date:  1988-02-15       Impact factor: 3.365

Review 2.  Epoxide hydrolases and their synthetic applications.

Authors:  R V Orru; A Archelas; R Furstoss; K Faber
Journal:  Adv Biochem Eng Biotechnol       Date:  1999       Impact factor: 2.635

3.  QSAR and classification of murine and human soluble epoxide hydrolase inhibition by urea-like compounds.

Authors:  Nathan R McElroy; Peter C Jurs; Christophe Morisseau; Bruce D Hammock
Journal:  J Med Chem       Date:  2003-03-13       Impact factor: 7.446

4.  Ligand-dependent conformational equilibria of serum albumin revealed by tryptophan fluorescence quenching.

Authors:  N Chadborn; J Bryant; A J Bain; P O'Shea
Journal:  Biophys J       Date:  1999-04       Impact factor: 4.033

5.  cDNA cloning and expression of a soluble epoxide hydrolase from human liver.

Authors:  J K Beetham; T Tian; B D Hammock
Journal:  Arch Biochem Biophys       Date:  1993-08-15       Impact factor: 4.013

6.  Improved radiolabeled substrates for soluble epoxide hydrolase.

Authors:  B Borhan; T Mebrahtu; S Nazarian; M J Kurth; B D Hammock
Journal:  Anal Biochem       Date:  1995-10-10       Impact factor: 3.365

7.  Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility.

Authors:  In-Hae Kim; Christophe Morisseau; Takaho Watanabe; Bruce D Hammock
Journal:  J Med Chem       Date:  2004-04-08       Impact factor: 7.446

8.  Molecular cloning and expression of murine liver soluble epoxide hydrolase.

Authors:  D F Grant; D H Storms; B D Hammock
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

9.  Soluble epoxide hydrolase: a novel therapeutic target in stroke.

Authors:  Wenri Zhang; Ines P Koerner; Ruediger Noppens; Marjorie Grafe; Hsing-Ju Tsai; Christophe Morisseau; Ayala Luria; Bruce D Hammock; John R Falck; Nabil J Alkayed
Journal:  J Cereb Blood Flow Metab       Date:  2007-04-18       Impact factor: 6.200

10.  Spectrophotometric substrates for cytosolic epoxide hydrolase.

Authors:  E C Dietze; E Kuwano; B D Hammock
Journal:  Anal Biochem       Date:  1994-01       Impact factor: 3.365

View more
  8 in total

1.  Evidence of vanillin binding to CAMKIV explains the anti-cancer mechanism in human hepatic carcinoma and neuroblastoma cells.

Authors:  Huma Naz; Mohd Tarique; Parvez Khan; Suaib Luqman; Shahzaib Ahamad; Asimul Islam; Faizan Ahmad; Md Imtaiyaz Hassan
Journal:  Mol Cell Biochem       Date:  2017-07-25       Impact factor: 3.396

2.  Fluorescence studies on the stability, flexibility and substrate-induced conformational changes of acetate kinases from psychrophilic and mesophilic bacteria.

Authors:  Md Abul Kashem Tang; Hiroyuki Motoshima; Keiichi Watanabe
Journal:  Protein J       Date:  2012-04       Impact factor: 2.371

3.  Group IIA secreted phospholipase A2 inhibition by elemolic acid as a function of anti-inflammatory activity.

Authors:  Aladahalli S Giresha; Deepadarshan Urs; J G Manjunatha; P Sophiya; B H Supreetha; Shankar Jayarama; K K Dharmappa
Journal:  Sci Rep       Date:  2022-05-10       Impact factor: 4.996

4.  Förster resonance energy transfer competitive displacement assay for human soluble epoxide hydrolase.

Authors:  Kin Sing Stephen Lee; Christophe Morisseau; Jun Yang; Peng Wang; Sung Hee Hwang; Bruce D Hammock
Journal:  Anal Biochem       Date:  2012-12-05       Impact factor: 3.365

5.  Substitution at the C-3 Position of Catechins Has an Influence on the Binding Affinities against Serum Albumin.

Authors:  Masaki Ikeda; Manabu Ueda-Wakagi; Kaori Hayashibara; Rei Kitano; Masaya Kawase; Kunihiro Kaihatsu; Nobuo Kato; Yoshitomo Suhara; Naomi Osakabe; Hitoshi Ashida
Journal:  Molecules       Date:  2017-02-18       Impact factor: 4.411

6.  Sinapicacid Inhibits Group IIA Secretory Phospholipase A2 and Its Inflammatory Response in Mice.

Authors:  Aladahalli S Giresha; Deepadarshan Urs; Sophiya Pundalik; Rajkumar S Meti; Siddanakoppalu N Pramod; Ballenahalli H Supreetha; Madhusudana Somegowda; Kattepura K Dharmappa; Ahmed M El-Shehawi; Sarah Albogami; Mona M Elseehy; Abdullah Alaklabi; Hosam O Elansary; Alanoud Omur A Mehder; Eman A Mahmoud
Journal:  Antioxidants (Basel)       Date:  2022-06-25

7.  Bordetella pertussis FbpA binds both unchelated iron and iron siderophore complexes.

Authors:  Sambuddha Banerjee; Aruna J Weerasinghe; Claire J Parker Siburt; R Timothy Kreulen; Sandra K Armstrong; Timothy J Brickman; Lisa A Lambert; Alvin L Crumbliss
Journal:  Biochemistry       Date:  2014-06-13       Impact factor: 3.162

8.  Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy.

Authors:  Kin Sing Stephen Lee; Jun-Yan Liu; Karen M Wagner; Svetlana Pakhomova; Hua Dong; Christophe Morisseau; Samuel H Fu; Jun Yang; Peng Wang; Arzu Ulu; Christina A Mate; Long V Nguyen; Sung Hee Hwang; Matthew L Edin; Alexandria A Mara; Heike Wulff; Marcia E Newcomer; Darryl C Zeldin; Bruce D Hammock
Journal:  J Med Chem       Date:  2014-08-11       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.